Company News

J&J and The Skin Microbiome

New collaboration announced with bio-tech firm Xycrobe Therapeutics (video).

Author Image

By: Christine Esposito

Editor-in-Chief

Xycrobe Therapeutics, La Jolla, CA, has entered into a research agreement with Johnson & Johnson Consumer Inc. designed to further understanding applications of Xycrobe's platform technology developed for the treatment of inflammatory skin diseases.   Xycrobe's technology consists of a library of commensal strains from the skin microbiome engineered to grow and secrete biotherapeutics as needed to help treat an array of skin issues.   The planned collaboration is intended to p...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters